Pathogenesis and treatment of myasthenia gravis.
作者信息
Scadding G K, Havard C W
出版信息
Br Med J (Clin Res Ed). 1981 Oct 17;283(6298):1008-12. doi: 10.1136/bmj.283.6298.1008.
Abstract
摘要
相似文献
1
Pathogenesis and treatment of myasthenia gravis.重症肌无力的发病机制与治疗
Br Med J (Clin Res Ed). 1981 Oct 17;283(6298):1008-12. doi: 10.1136/bmj.283.6298.1008.
2
Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.重症肌无力的科学概述及血浆置换作用评估
Prog Clin Biol Res. 1982;106:113-42.
3
Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.重症肌无力患者胸腺切除术后抗乙酰胆碱受体抗体水平降低。临床相关性。
J Autoimmun. 1991 Apr;4(2):197-211. doi: 10.1016/0896-8411(91)90018-8.
4
Myasthenia gravis, the acetylcholine receptor and the immune response.重症肌无力、乙酰胆碱受体与免疫反应。
Int J Immunopharmacol. 1979;1(4):263-71. doi: 10.1016/0192-0561(79)90002-x.
5
[Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl].
Helv Paediatr Acta. 1979 Sep;34(4):375-80.
6
Myasthenia gravis.重症肌无力
Ann Ital Med Int. 1988;3 Suppl 1:32-7.
7
[Myasthenia gravis: an autoimmune theory].重症肌无力：一种自身免疫理论
Nihon Rinsho. 1973 Dec;31(12):3387-93.
8
Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.重症肌无力患者胸腺切除术后抗乙酰胆碱受体抗体浓度
Br Med J. 1978 Oct 14;2(6144):1051-3. doi: 10.1136/bmj.2.6144.1051.
9
Myasthenia gravis and immunity. A review of basic mechanisms.重症肌无力与免疫。基本机制综述。
J Kans Med Soc. 1973 Mar;74(3):72-7.
10
[Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
Wiad Lek. 1992 Aug;45(15-16):610-4.
引用本文的文献
1
An Atypical Presentation of Myasthenia Gravis: A Case Report.重症肌无力的非典型表现：一例报告
Cureus. 2019 Apr 29;11(4):e4563. doi: 10.7759/cureus.4563.
2
Pathogenesis and treatment of myasthenia gravis.重症肌无力的发病机制与治疗
Br Med J (Clin Res Ed). 1981 Nov 14;283(6302):1332-3. doi: 10.1136/bmj.283.6302.1332-d.
3
Bilateral intracavernous carotid aneurysms presenting as pseudo-ocular myasthenia gravis.表现为假性眼肌型重症肌无力的双侧海绵窦内颈动脉瘤
Trans Am Ophthalmol Soc. 1989;87:445-57; discussion 457-62.
本文引用的文献
1
ISOLATION OF NEUROTOXINS FROM THE VENOM OF BUNGARUS MULTICINCTUS AND THEIR MODES OF NEUROMUSCULAR BLOCKING ACTION.从银环蛇毒液中分离神经毒素及其神经肌肉阻断作用方式
Arch Int Pharmacodyn Ther. 1963 Jul 1;144:241-57.
2
Changes in serum complement activity in patients with myasthenia gravis.重症肌无力患者血清补体活性的变化
Proc Soc Exp Biol Med. 1960 Oct;105:177-84. doi: 10.3181/00379727-105-26050.
3
Plasma pyridostigmine levels in myasthenia gravis.重症肌无力患者的血浆吡啶斯的明水平
Neurology. 1981 Feb;31(2):145-50. doi: 10.1212/wnl.31.2.145.
4
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.重症肌无力疾病异质性的临床、病理、HLA抗原及免疫学证据
Brain. 1980 Sep;103(3):579-601. doi: 10.1093/brain/103.3.579.
5
Autoimmune response to acetylcholine receptor.对乙酰胆碱受体的自身免疫反应。
Science. 1973 May 25;180(4088):871-2. doi: 10.1126/science.180.4088.871.
6
Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.重症肌无力中的血清球蛋白：对α-银环蛇毒素与乙酰胆碱受体结合的抑制作用
Science. 1974 Oct 4;186(4158):55-7. doi: 10.1126/science.186.4158.55.
7
The effect of thoracic duct lymph drainage in myasthenia gravis.
Eur Neurol. 1973;9(3):157-67. doi: 10.1159/000114221.
8
Towards a network theory of the immune system.迈向免疫系统的网络理论。
Ann Immunol (Paris). 1974 Jan;125C(1-2):373-89.
9
Myasthenia gravis: passive transfer from man to mouse.重症肌无力：从人到小鼠的被动转移
Science. 1975 Oct 24;190(4212):397-9. doi: 10.1126/science.1179220.
10
Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.与青霉胺治疗类风湿关节炎相关的重症肌无力。
Br Med J. 1975 Mar 15;1(5958):600-2. doi: 10.1136/bmj.1.5958.600.
Zotero 插件